1-4 of 4
Urte Hilbers
Close
Sort by
Journal Articles

Patients Receiving IL-2 Activated Donor NK Cells Show Lower Incidence of Severe GvHD after Haploidentical SCT.

Chiara Gentilini, MD, Urte Hilbers, Volker Huppert, Christoph Loddenkemper, MD, Arne Müßig, MD, Constanze Kliem, MD, Thoralf Lange, MD, Nadezda Basara, Marcus Uhrberg, Eckhard Thiel, Dietger W. Niederwieser, Lutz Uharek
Journal: Blood
Blood (2007) 110 (11): 354.
https://doi.org/10.1182/blood.V110.11.354.354
Published: 2007
Journal Articles

Treatment of Myeloid and Lymphoid Malignancies with Highly Purified Alloreactive CD56+CD3− NK-Cells and Haploidentical Stem Cell Transplantation: Promising Results of a Phase I Study.

Chiara Gentilini, MD, Urte Hilbers, Goetz Hartung, MD, Thoralf Lange, MD, Constanze Kliem, MD, Ute Hegenbart, MD, Mathias Zeis, MD, Volker Huppert, Bertram Glass, Marcus Uhrberg, Norbert Schmitz, Eckhard Thiel, Dietger W. Niederwieser, Lutz Uharek
Journal: Blood
Blood (2005) 106 (11): 2906.
https://doi.org/10.1182/blood.V106.11.2906.2906
Published: 2005
Journal Articles

CMV-Seropositive Patients Allografted with a CMV-Seronegative Donor Show Delayed or Missing CMV-Specific T-Cell Immune Response and Are at Higher Risk for CMV-Viremia and CMV-Disease.

Susanne Ganepola, Chiara Gentilini, Urte Hilbers, Goetz Hartung, Thoralf Lange, Joerg Hofmann, Uwe G. Liebert, Markus Hammer, Elisabeth Engelmann, Dietger Niederwieser, Eckhard Thiel, Lutz Uharek
Journal: Blood
Blood (2005) 106 (11): 3249.
https://doi.org/10.1182/blood.V106.11.3249.3249
Published: 2005
Journal Articles

WT1-Specific T Cell Responses Are Frequent after Allogeneic Stem Cell Transplantation for Acute and Chronic Myeloid Leukemia.

Chiara Gentilini, MD, Urte Hilbers, Susanne Ganepola, MD, Carmen Scheibenbogen, Katy Freyberg, Dietger W. Niederwieser, Eckhard Thiel, Lutz Uharek
Journal: Blood
Blood (2005) 106 (11): 598.
https://doi.org/10.1182/blood.V106.11.598.598
Published: 2005